Analysts Set Donaldson Co. (NYSE:DCI) Target Price at $34.00

Donaldson Co. - Get News & Ratings Daily Enter your email address below to get the latest news and analysts' ratings for Donaldson Co. with our FREE daily email newsletter: Follow Ticker Report       Recent Posts

Palo Alto Networks Inc. (PANW) Insider Nir Zuk Sells 76,848 Shares of Stock

Amber Road Inc. (AMBR) Director Donald R. Caldwell Sells 1,450,000 Shares

AcelRx Pharmaceuticals Inc. (ACRX) Major Shareholder Perceptive Advisors Llc Sells 392,850 Shares

Equities Analysts Set Expectations for Anheuser Busch Inbev SA's FY2016 Earnings (BUD)

Analysts Set Pagegroup PLC (LON:PAGE) Price Target at $316.13

Canadian Imperial Bank of Commerce (TSE:CM) Receives C$103.75 Consensus PT from Analysts

Snyder's-Lance Inc. (NASDAQ:LNCE) Receives $36.46 Average Target Price from Brokerages

Analysts Set Donaldson Co. (NYSE:DCI) Target Price at $34.00

Trovagene Inc. (NASDAQ:TROV) Receives Consensus Rating of "Hold" from Analysts

Brokerages Set Flowers Foods Inc. (NYSE:FLO) PT at $17.57

Crescent Point Energy Corp. (NYSE:CPG) Receives Average Recommendation of "Buy" from Brokerages

Franklin Financial Services Corp (FRAF) Director Acquires $24,450.00 in Stock

Analysts Issue Forecasts for Fibrocell Science Inc.'s FY2016 Earnings (FCSC)

Analysts Issue Forecasts for Fibrocell Science Inc.'s FY2016 Earnings (FCSC)

UFP Technologies Inc. (UFPT) Upgraded at Zacks Investment Research

Redwood Trust Inc. (NYSE:RWT) Receives $15.58 Consensus Target Price from Analysts

California First National Bancorp (NASDAQ:CFNB) Receives $27.00 Average Price Target from Analysts

Select Medical Holdings Corp. (NYSE:SEM) Receives $17.00 Average Price Target from Analysts

Brokerages Set TransGlobe Energy Co. (TSE:TGL) PT at $3.13

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Given Average Recommendation of "Hold" by Analysts